The plan allows CVS to buy back its stock over the open market and via private agreements, as well as other derivative transactions. The company has said it will outline in further detail its capital allocation plans for 2013 on “Analyst Day” Dec. 13.
CVS shares closed up 0.66% Wednesday, outperforming the S&P 500 by about half a percentage point.
The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.